Hormonal control of inhibin B in men

Journal of Endocrinological Investigation

Volumn 29, Issue 8, 2006, Pages 706-713

  Giagulli, V A ^a   Carbone, D ^b  

^a OU Internal Medicine   (Italy)

^b Institute of Clinical and Hormonal Research   (Italy)

Author keywords

Follicle stimulating hormone; Growth hormone; Inhibin B; Luteinizing hormone; Prolactin; Testosterone

Indexed keywords

CABERGOLINE; CHORIONIC GONADOTROPIN; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; INHIBIN B; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; RECOMBINANT FOLLITROPIN; RECOMBINANT GROWTH HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AZOOSPERMIA; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOPITUITARISM; MALE; PROLACTIN BLOOD LEVEL; SERTOLI CELL; SPERMATOGENESIS; TESTOSTERONE BLOOD LEVEL;

EID: 33751024271     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344180     Document Type: Article

References (55)

1. Orth JM. The role of follicle-stimulating hormone in controlling Sertoli cell proliferation in testes of fetal rats. Endocrinology 1984, 115: 1248-55.
2. Pierik FH, Vreeburg JT, Stijnen T, De Jong FH, Weber RFA. Serum Inibin B as a marker of spermatogenisis. J Clin Endocrinol Metab 1998, 83: 3110-4.
3. Anawalt BD, Bebb RA, Matsumoto AM, et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996, 81: 3341-5.
4. Kinniburgh D, Andreson RA. Differential patterns of inhibin secretion in response to gonadotrophin stimulation in normal men. Int J Androl 2001, 24: 95-101.
5. Andersson AM, Juul A, Pertersen JH, Muller J, Groome NP, Skakkebaek NE. Serum inhibin B in healthy pubertal and adolescent boys: relation to age, stage of puberty, follicle-stimulating hormone, luteinizing hormone, testosterone, and estradiol levels. J Clin Endocrinol Metab 1997, 82: 3976-81.
6. Chada M, Prusa R, Bronsky J, et al. Inhibin B, follicle stimulating hormone, luteinizing hormone and testosterone during childhood and puberty in males: changes in serum concentrations in relation to age and stage of puberty. Physiol Res 2003, 52: 45-51.
7. Mahmoud AM, Goemaere S, De Bacquer D, Comhaire FH, Kaufman JM. Serum inhibin B levels in community-dwelling elderly men. Clin Endocrinol (Oxf) 2000, 53: 141-7.
8. Mahmoud AM, Goemaere S, El-Garem Y, Van Pottelbergh I, Comhaire FH, Kaufman JM. Testicular volume in relation to hormonal indices of gonadal functions in community-dwelling elderly men. J Clin Endocrinol Metab 2003, 88: 179-84.
9. Kamischke A, Behre HM, Bergmann M, Simoni M, Schafer T, Neischlag E. Recombinant human follicle stimulating hormone for treatment of male idiopathic infertility: a randomized, double-blind, placebo-controlled clinical trial. Hum Reprod 1998, 13: 596-603.
10. Kamischke A, Simoni M, Schrameyer K, Lerchl A, Neischlag E. Is inhibin B a pharmacodynamic parameter of FSH in normal men? Eur J Endocrinol 2001, 144: 629-37.
11. Andersson AM, Petersen JH, Jorgensen N, Jensen TK, Skakkebaek E. Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab 2004, 89: 2873-9.
12. Guillaumot P, Tabone E, Benahmed M. Sertoli cells as potential targets of prolactin action in the testis. Mol Cell Endocrinol 1996, 18: 199-206.
13. Takase M, Tsutsui K. Inhibitory role of prolactin in the down regulation of testicular follicle-stimulating hormone receptors in mice. J Exp Zool 1997, 278: 234-42.
14. Jabbour HN, Lincoln GA. Prolactin receptor expression in the testis of the ram: location, functional activation and the influence of gonadotrophins. Mol Cell Endocrinol 1999, 148: 151-61.
15. Guillaumot P, Benahmed M. Prolactin receptor are expressed and hormonally regulated in rat Sertoli cells. Mol Cell Endocrinol 1999, 149: 163-8.
16. Scarabelli L, Caviglia D, Bottazzi C, Palmero S. Prolactin effect on pre-puberal Sertoli cell proliferation and metabolism. J Endocrinol Invest 2003, 26: 718-22.
17. Shoham Z, Lahlou A, Conway GS, Boucahrd P, Ostergaard H, Jacobs HS. Cotreatment with growth hormone for inductions spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril 1992, 57: 1044-50.
18. Shoham Z, Zalec Y, Jacobs HS. The role of growth hormone in male infertility. Clin Endocrinol (Oxf) 1994, 41: 1-5.
19. Ovesen P, Lunde Jorgensen JO, Ingerslev HJ, et al. Impaired growth hormone secretion and increased growth hormone binding protein levels in subfertile males. Fertil Steril 1996, 65: 165-9.
20. Bartke A. Effects of growth hormone on male reproductive functions. J Androl 2000, 21: 181-8.
21. Fujisawa M, Yamanaka K, Okada H, Arakawa S, Kamidono S. Growth hormone realising test for infertile men with spermatogenesis maturation arrest. J Urol 2002, 168: 2083-5.
22. Chandrashekar V, Zaczek D, Bartke A. The consequence of alterated somatotropic system on reproduction. Biol Reprod 2004, 71: 17-27.
23. World Health Organization: WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge, UK: Cambridge University Press. 1992.
24. Giagulli VA. Absence of effect of recombinant growth hormone to classic gonadotropine treatment on spermatogenesis of patients with severe hypogonadortropic hypogonadism. Arch Androl 1999, 43: 47-53.
25. Giagulli VA, Vermeulen A. Leydig cell function in infertile men with idiopathic oligospermic infertility. J Clin Endocrinol Metab 1988, 66: 62-7.
26. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84: 3666-72.
27. Young J, Couzinet B, Chanson P, Brailly S, Loumaye E, Schainson G. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretion and interaction. J Clin Endocrinol Metab 2000, 85: 3239-44.
28. Anawalt BD, Bebb RA, Matsumoto AM, et al. Serum inhibin B levels reflect Sertoli cell function in normal men and men with testicular dysfunction. J Clin Endocrinol Metab 1996, 81: 3341-5.
29. Adamopoulos D, Kapolla N, Nicopoulou S, Pappa A, Koukkou E, Gregoriou A. Assessment of Sertoli cell functional reserve and its relationship to sperm parameters. Int J Androl 2003, 26: 215-25.
30. Foresta C, Bettella A, Merico M, Garolla A, Ferlin A, Rossato M. Use of recombinant follicle-stimulating hormone in the treatment of male factor infertility, Fertil Steril 2002, 77: 238-44.
31. Sharpe RM, Kerr JB, Maddocks S. Evidence for a role of the Leydig cells in control of the intratesticular secretion of inhibin. Mol Cell Endocrinol 1988, 60: 243-7.
32. Drummond AE, Risbridger GP, de Kretser MD. The involvement of Leydig cells in the regulation of inhibin secretion by the testis. Endocrinology 1989, 125: 510-5.
33. Fingscheidt U, Nieschlag E. The response of inhibin to human chorionic gonadotrophin is decreased in senescent men compared with young men. J Endocrinol 1989, 123: R9-11.
34. McLachlan RI, Finkel DM, Bremner WJ, Snyder PJ. Serum Inhibin concentration before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications. J Clin Endocrinol Metab 1990, 70: 1414-9.
35. Krishnamurthy H, Danilovich N, Morales CR, Sairam MR, Qualitative and quantitative decline in spermatogenesis of follicle-stimulating hormone receptor knockout (FORKO) mouse. Biol Reprod 2000, 62: 1146-59.
36. Nachtigall LB, Boeple PA, Seminara SB, et al. Inhibin B secretion in males with gonodotropin-releasing hormone (GnRH) deficiency before and during long-term GnRH replacement: relationship to spontaneous puberty, testicular volume, and prior treatment - a clinical research centre study. J Clin Endocrinol Metab 1996, 81: 3520-5.
37. Awoniyi CA, Zickin BR, Chandrashekar V, Schalaff WD. Exogenously administered testosterone maintains spermatogenesis quantitatively in adult rats actively immunized against gonadotropine-releasing hormone. Endocrinology 1992, 130: 3283-8.
38. Singh J, O'Neill C, Handelsman DJ. Induction of spermatogenesis by androgens gonadotropin-deficient (hpg) mice. Endocrinology 1995, 136: 5311-21.
39. De Gendt K, Swinnen JV, Saunders PTK, et al. A Sertoli cell-selective knockout of the androgen receptor causes spermatogenesis arrest in meiosis. Proc Natl Acad Sci U S A 2004, 3: 327-32.
40. Mariggiola MC, Costantino A, Bremmer WJ, Morselli-Labate AM. Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen. J Androl 2002, 23: 684-90.
41. McLachlan RI, O'Donnell L, Meachem SJ, et al. Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man. Recent Prog Horm Res 2002, 57: 149-79
42. Matthiesson KL, Staton PG, O'Donnel L, et al. Effects of testosterone and Levonorgestrel combined with a 5a-reductase inhibitor or gondotropin-releasing hormone antagonist on spermatogenesis and intratesticular steroid levels in normal men. J Clin Endocrinol Metab 2005, 90: 5647-55.
43. Johnsen SG. Maintenance of spermatogenesis induced by hMG treatment by means of continuous hCG treatment in hypogonadotophic men. Acta Endocrinol (Copenh) 1978, 89: 63-9.
44. Kibuni K, Zachmann M, Albers N, et al. Basal inhibin B and testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 2000, 85: 134-8.
45. Matsumoto AM, Karpas AE, Paulsen CA, Bremmer WJ. Reinitiation of sperm production in gonadotropin-suppressed normal men by administration of follicle-stimulating hormone. J Clin Invest 1983, 72: 1005-15.
46. Abbaticchio GF, Micale FM, Giagulli VA, Giorgino R. Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment. Arch Androl 1985, 15: 59-64.
47. Burcher D, Behre HM, Kliesch S, Nieschlag E. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 1998, 139: 298-303.
48. Barrio R, de Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril 1999, 71: 244-8.
49. Liu PY, Turner L, Rushford D, et al, Efficacy and safety of recombinant human follicle stimulating hormone (Gonal F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin deficient men. Hum Reprod 1999, 14: 1540-5.
50. Carani C, Granata AR, De Rosa M, et al. The effect of chronic treatment with GH on gonadal function in men with isolated GH definciency. EurJ Endocrinol 1999, 140: 224-30.
51. Illingworth PJ, Groome NP, Byrd W, et al. Inhibin B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996, 81: 1321-30.
52. Hayes FJ, Hall JE, Boepple PA, Crowley WF Jr. Clinical review 96: Differential control of gonadotropine secretion in the human: endocrine role of inhibin. J Clin Endocrinol Metab 1998, 83: 1835-41.
53. Andresson AM, Jorgensen N, Frydelund-Larsen L, Rajpert-De Meyts E, Skakkebaek E. Impaired Leydig cell function in infertile men: study of 357 idiopathic infertile men and 318 proven fertile controls. J Clin Endocrinol Metab 2004, 89: 3161-7.
54. Winters SJ, Troen P. Altered pulsatile secretion of luteinizing hormone in hypogonadal men with hyperprolactinaemia. Clin Endocrinol (Oxf) 1984, 21: 257-63.
55. Fuchs E, Mansky T, Stock KW, Vijayan E, Wuttke W. Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion. Neuroendocrinol 1984, 38: 484-9.